Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT05871658
Eligibility Criteria:
Inclusion Criteria:
1. people diagnosed as NMOSD according to the International Panel for NMO Diagnosis (IPND) criteria.\[21\]
2. NRSā„4.
3. people were treated with stable doses of biological therapy and/or prednisone, with no regimen adjustment within 30 days prior to enrollment.
4. people did not adjust any standard pain medication combinations, including antiepileptic drugs, antidepressants, and opioids, within 30 days before enrollment.
5. people or their families provided written informed consent.
Exclusion Criteria:
1. people enrolled in other clinical studies.
2. people with low cognitive or mental ability.
3. people who became pregnant during the study period, breastfed, or planned to become pregnant.
4. people with serious diseases related to the heart, liver, kidney or hematopoietic system.
5. people with diabetic peripheral neuropathy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05871658
Study Brief:
Protocol Section:
NCT05871658